Search
Search Results
- Publication:
- [Washington, D.C.] : AcademyHealth, [2005]
- Subject(s):
- Cost Control
Medicare -- economics
State Health Plans -- economics
Cost Sharing
Drug Costs
Drug Utilization Review
Drugs, Generic
Fees, Pharmaceutical
Formularies as Topic
Insurance Coverage -- legislation & jurisprudence
Insurance, Pharmaceutical Services -- economics
Insurance, Pharmaceutical Services -- legislation & jurisprudence
Medicare -- legislation & jurisprudence
Humans
United States
- Author(s):
- Doshi, Jalpa A., author
Li, Pengxiang, author
Huo, Hairong, author
Pettit, Amy R., author
Kumar, Rishab, author
Weiss, Brendan M., author
Huntington, Scott F., author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, 2016
- Subject(s):
- Cost Sharing
Drug Costs
Medicare Part D -- economics
Financing, Personal
Health Services Accessibility
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
Protein Kinase Inhibitors -- economics
Protein Kinase Inhibitors -- therapeutic use
Protein-Tyrosine Kinases -- antagonists & inhibitors
Humans
United States
- Author(s):
- Cubanski, Juliette, author
Neuman, Tricia, author
- Publication:
- San Francisco, CA : Henry J. Kaiser Family Foundation, April 2018
- Subject(s):
- Drug Costs
Medicare Part D -- economics
Negotiating
Prescription Drugs -- economics
Cost Savings
Humans
United States
- Author(s):
- Young, Katherine, author
- Publication:
- San Francisco, CA : Henry J. Kaiser Family Foundation, May 2018
- Subject(s):
- Cost Control
Drug Costs
Medicaid -- economics
Prescription Drugs -- economics
Formularies as Topic
Humans
United States
United States.
- Author(s):
- Dayoub, Elias J., author
Seigerman, Matthew, author
Tuteja, Sony, author
Kobayashi, Taisei, author
Kolansky, Daniel, author
Giri, Jay, author
Groeneveld, Peter, author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018
- Subject(s):
- Medication Adherence -- statistics & numerical data
Percutaneous Coronary Intervention
Purinergic P2Y Receptor Antagonists -- therapeutic use
Socioeconomic Factors
Drug Costs
Drugs, Generic -- economics
Drugs, Generic -- therapeutic use
Platelet Aggregation Inhibitors -- economics
Platelet Aggregation Inhibitors -- therapeutic use
Purinergic P2Y Receptor Antagonists -- economics
Social Determinants of Health
Humans
United States
- Publication:
- Oakland, Calif. : California HealthCare Foundation, [2008]
- Subject(s):
- Community Participation
Disclosure
Drug Costs
Information Services
Cost Control
Decision Making
Delivery of Health Care -- economics
Prescription Fees
Humans
California
United States
- Publication:
- Oakland, Calif. : California HealthCare Foundation, [2009]
- Subject(s):
- Health Expenditures -- trends
Insurance Benefits
Insurance, Pharmaceutical Services
Medicaid
Prescription Drugs -- economics
Adult
Aged
Child
Cost Control
Cost Sharing
Disabled Persons
Drug Costs
Drug Utilization Review
Drugs, Generic
Fee-for-Service Plans
Forecasting
Managed Care Programs
Medicare Part D
Middle Aged
Humans
California
- Publication:
- [New York, N.Y.] : Commonwealth Fund Commission on a High Performance Health System, [2007]
- Subject(s):
- Cost Savings
Health Expenditures -- trends
Quality Assurance, Health Care
Decision Making
Drug Costs
Forecasting
Federal Government
Health Policy
Health Promotion
Insurance Coverage
Insurance, Health
Medical Informatics
Obesity -- prevention & control
Smoking Cessation -- economics
State Government
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014
- Subject(s):
- Comparative Effectiveness Research
Hepatitis C, Chronic -- drug therapy
Heterocyclic Compounds, 3-Ring -- therapeutic use
Sulfonamides -- therapeutic use
Uridine Monophosphate -- analogs & derivatives
Uridine Monophosphate -- therapeutic use
Antiviral Agents -- economics
Antiviral Agents -- therapeutic use
Cost-Benefit Analysis
Drug Costs
Drug Therapy, Combination
Genotype
Hepatitis C -- economics
Hepatitis C -- genetics
Heterocyclic Compounds, 3-Ring -- adverse effects
Heterocyclic Compounds, 3-Ring -- economics
Insurance Coverage
Interferon-alpha -- therapeutic use
Oligopeptides -- therapeutic use
Polyethylene Glycols -- therapeutic use
Proline -- analogs & derivatives
Proline -- therapeutic use
Protease Inhibitors -- economics
Protease Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Ribavirin -- therapeutic use
Sulfonamides -- adverse effects
Technology Assessment, Biomedical
Treatment Outcome
Uridine Monophosphate -- adverse effects
Uridine Monophosphate -- economics
Value-Based Purchasing
Humans
United States
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, July 2014
- Subject(s):
- Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Delivery of Health Care
Health Policy
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Opiate Substitution Treatment -- economics
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- rehabilitation
Analgesics, Opioid -- administration & dosage
Analgesics, Opioid -- adverse effects
Budgets
Cohort Studies
Cost-Benefit Analysis
Counseling
Criminal Law
Drug Combinations
Drug Costs
Health Services Accessibility
Insurance Coverage
Medicaid
Medicare
Patient Care Team
Patient-Centered Care
Practice Guidelines as Topic
Treatment Outcome
Humans
New England
United States
